J9033 HCPCS code: Injection, bendamustine hydrochloride, 1 mg
J9033 is the HCPCS Level II code for injection, bendamustine hydrochloride, 1 mg. In 2024 Medicare paid an average of $5.34 per service for J9033 across 637,557 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 44% from 2022 to 2024 (442,766 to 637,557 services). In 2024, about 654 clinicians billed Medicare for J9033 for 617 beneficiaries; Florida, California, Tennessee accounted for 58% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2009-01-01 |
| Last action effective | 2025-01-01 |
Who bills J9033 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 654 |
| Medicare beneficiaries | 617 |
| States with claims | 15 |
| Share of services in top 3 states (Florida, California, Tennessee) | 58% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9033, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 442,766 | 463 | $18.12 | $14.48 |
| 2023 | 686,050 | 637 | $12.73 | $10.14 |
| 2024 | 637,557 | 617 | $6.71 | $5.34 |
States with the most J9033 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 187,804 | $5.73 |
| California | 87,421 | $5.11 |
| Tennessee | 49,846 | $5.34 |
| Indiana | 35,051 | $5.09 |
| Michigan | 33,077 | $6.05 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J9033
- 2009-01-01: J9033 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9033?
J9033 is the HCPCS Level II code for injection, bendamustine hydrochloride, 1 mg. Short descriptor: "Inj, bendamustine hcl, 1mg".
How much does Medicare pay for J9033?
In 2024, the average Medicare payment was $5.34 per service (average allowed $6.71).
Does Medicare cover J9033?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9033 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9033
- Watch J9033 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9033
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.